In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203)

Hepatitis A virus (HAV) replicates relatively slowly in cell culture without a cytopathic effect, a fact that limits the use of tissue culture assays. The radioimmunofocus assay is the standard method for HAV titration, although it is labor intensive and requires the use of radioisotopes. A simple,...

Full description

Bibliographic Details
Main Authors: L.M. Villar, L.A. Amado, A.M.C. Gaspar
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2004-07-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000700011
_version_ 1819211651734306816
author L.M. Villar
L.A. Amado
A.M.C. Gaspar
author_facet L.M. Villar
L.A. Amado
A.M.C. Gaspar
author_sort L.M. Villar
collection DOAJ
description Hepatitis A virus (HAV) replicates relatively slowly in cell culture without a cytopathic effect, a fact that limits the use of tissue culture assays. The radioimmunofocus assay is the standard method for HAV titration, although it is labor intensive and requires the use of radioisotopes. A simple, rapid and objective infectivity assay based on an in situ enzyme immunoassay (EIA) is described here for a Brazilian cell culture-adapted HAV strain (HAF-203). The assay uses a peroxidase-labeled polyclonal antibody to fixed monolayers as an indicator of infection. EIA may be completed within 7 days using serial 5-fold dilutions of the virus, yielding a titer of 5.024 log 50% tissue culture infective dose (TCID50)/ml for HAF-203. This technique had a detection limit of 1.1 log TCID50/ml and the specificity was demonstrated by detecting no reaction on the columns of uninfected wells. The reproducibility (with intra- and inter-assay coefficients of variation ranging from 1.9 to 3.8% and from 3.5 to 9.9%, respectively) and quantitation of the assay were demonstrated by close agreement in virus infectivity titers among different assays of the same amount of virus and between assays of different amounts of virus. Furthermore, this assay does not require the use of radiolabeled antibodies. We describe here an efficient EIA that is highly reproducible and that could be used to monitor HAV growth in cell culture and to determine the quantity of HAV antigen needed for diagnostic assays. This is the first report of the infectious titer of the Brazilian cell culture-adapted HAV strain (HAF-203).
first_indexed 2024-12-23T06:30:28Z
format Article
id doaj.art-b3d7b7df79f5439284667fe144e79d92
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-23T06:30:28Z
publishDate 2004-07-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-b3d7b7df79f5439284667fe144e79d922022-12-21T17:56:57ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2004-07-013771023102710.1590/S0100-879X2004000700011In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203)L.M. VillarL.A. AmadoA.M.C. GasparHepatitis A virus (HAV) replicates relatively slowly in cell culture without a cytopathic effect, a fact that limits the use of tissue culture assays. The radioimmunofocus assay is the standard method for HAV titration, although it is labor intensive and requires the use of radioisotopes. A simple, rapid and objective infectivity assay based on an in situ enzyme immunoassay (EIA) is described here for a Brazilian cell culture-adapted HAV strain (HAF-203). The assay uses a peroxidase-labeled polyclonal antibody to fixed monolayers as an indicator of infection. EIA may be completed within 7 days using serial 5-fold dilutions of the virus, yielding a titer of 5.024 log 50% tissue culture infective dose (TCID50)/ml for HAF-203. This technique had a detection limit of 1.1 log TCID50/ml and the specificity was demonstrated by detecting no reaction on the columns of uninfected wells. The reproducibility (with intra- and inter-assay coefficients of variation ranging from 1.9 to 3.8% and from 3.5 to 9.9%, respectively) and quantitation of the assay were demonstrated by close agreement in virus infectivity titers among different assays of the same amount of virus and between assays of different amounts of virus. Furthermore, this assay does not require the use of radiolabeled antibodies. We describe here an efficient EIA that is highly reproducible and that could be used to monitor HAV growth in cell culture and to determine the quantity of HAV antigen needed for diagnostic assays. This is the first report of the infectious titer of the Brazilian cell culture-adapted HAV strain (HAF-203).http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000700011Hepatitis A virusVirus titrationEnzyme immunoassay
spellingShingle L.M. Villar
L.A. Amado
A.M.C. Gaspar
In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203)
Brazilian Journal of Medical and Biological Research
Hepatitis A virus
Virus titration
Enzyme immunoassay
title In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203)
title_full In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203)
title_fullStr In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203)
title_full_unstemmed In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203)
title_short In situ enzyme immunoassay for titration of a Brazilian hepatitis A virus strain (HAF-203)
title_sort in situ enzyme immunoassay for titration of a brazilian hepatitis a virus strain haf 203
topic Hepatitis A virus
Virus titration
Enzyme immunoassay
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000700011
work_keys_str_mv AT lmvillar insituenzymeimmunoassayfortitrationofabrazilianhepatitisavirusstrainhaf203
AT laamado insituenzymeimmunoassayfortitrationofabrazilianhepatitisavirusstrainhaf203
AT amcgaspar insituenzymeimmunoassayfortitrationofabrazilianhepatitisavirusstrainhaf203